Cwm LLC Purchases 16,103 Shares of UnitedHealth Group Incorporated $UNH

Cwm LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 133,461 shares of the healthcare conglomerate’s stock after purchasing an additional 16,103 shares during the quarter. Cwm LLC’s holdings in UnitedHealth Group were worth $41,636,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the stock. Lakeridge Wealth Management LLC grew its holdings in UnitedHealth Group by 5.8% in the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock worth $220,000 after purchasing an additional 23 shares during the period. Nabity Jensen Investment Management Inc grew its holdings in shares of UnitedHealth Group by 0.9% during the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after buying an additional 24 shares during the last quarter. BigSur Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 0.5% during the first quarter. BigSur Wealth Management LLC now owns 4,743 shares of the healthcare conglomerate’s stock valued at $2,484,000 after buying an additional 25 shares during the last quarter. Atlantic Edge Private Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 8.9% during the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after buying an additional 25 shares during the last quarter. Finally, Stewardship Advisors LLC grew its holdings in shares of UnitedHealth Group by 4.1% during the first quarter. Stewardship Advisors LLC now owns 663 shares of the healthcare conglomerate’s stock valued at $347,000 after buying an additional 26 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $354.30 on Friday. The firm has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a P/E/G ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The firm’s 50-day simple moving average is $318.21 and its two-hundred day simple moving average is $349.25.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% on a year-over-year basis. During the same period in the prior year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is 38.30%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on UNH. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Truist Financial boosted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.